Erice, Italy
May 5 - May 6, 2006
The aim of this symposium is to provide an updated overview of the latest advances in the field of human implantation.
Biotechnological innovations will help understand the different aspects of the mechanisms of implantation from the endometrial and embryonic point of view. The participants will have an updated knowledge on the role of human gamete quality on implantation rates, the molecular and immunological aspects in endometrial-embryonic communication and the advances in the genetic control of implantation.
OBJECTIVES
After attending this course, the participants will be able to:
- Understand the genetic basis of human implantation;
- Evidence Biotechnological evolution in ART programs;
- Understand endometrial, gametes and embryo determinants of implantation;
- Reach a consensus within the scientific community on this crucial matter.
TARGET AUDIENCE
Reproductive endocrinologists, embryologists, basic scientists and other related health professionals will benefit from this meeting.
Serono Symposia International Foundation (www.seronosymposia.org) has submitted the following CME activity for accreditation by the European Accreditation Council for Continuing Medical Education (EACCME).
This program “Human Implantation: The New Frontiers of Human Assisted Reproductive Technologies” (May 5-6, 2006, Erice, Italy) has been approved by EACCME for a maximum of 12 (twelve) hours of European external CME credits. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.
The Italian National Commission for Continuing Medical Education has accredited this Serono Symposia International Foundation event, n. 10045 - 235926, entitled “Human Implantation: The New Frontiers of Human Assisted Reproductive Technologies” (Erice, Italy - May 5-6, 2006), for 9 (nine) CME credits.
Serono Symposia International Foundation has submitted this program for CME accreditation by the Royal College of Physicians (UK).